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NG2 proteoglycanEmbryonic mesoangioblasts are the in vitro counterpart of vessel-associated progenitors, able to differentiate
into different mesoderm cell types. To investigate signals recruiting these progenitors to a skeletal myogenic
fate, we developed an in vitro assay, based upon co-culture of E11.5 dorsal aorta (fromMLC3 F-nLacZ transgenic
embryos, expressing nuclear beta galactosidase only in striated muscle) with differentiating C2C12 or primary
myoblasts. Under these conditions muscle differentiation from cells originating from the vessel can be quanti-
ﬁed by counting the number of beta gal+nuclei. Results indicated that Noggin (but not Follistatin, Chordin or
Gremlin) stimulates while BMP2/4 inhibits myogenesis from dorsal aorta progenitors; neutralizing antibodies
and shRNA greatly reduce these effects. In contrast, TGF-β1, VEGF, Wnt7A, Wnt3A, bFGF, PDGF-BB and IGF1
have no effect. Sorting experiments indicated that the majority of these myogenic progenitors express the peri-
cyte marker NG2. Moreover they are abundant in the thoracic segment at E10.5 and in the iliac bifurcation at
E11.5 suggesting the occurrence of a cranio-caudal wave of competent cells along the aorta. BMP2 is expressed
in the dorsal aorta and Noggin in newly formed muscle ﬁbers suggesting that these two tissues compete to re-
cruit mesoderm cells to a myogenic or to a perithelial fate in the developing fetal muscle.
© 2012 Elsevier Inc.Open access under CC BY-NC-ND license. Introduction
Classic transplantation experiments showed, and recent data con-
ﬁrmed that all skeletal myoblasts of the vertebrate body originate
from somites (Buckingham et al., 2003; Christ and Ordahl, 1995),
blocks of paraxial mesoderm that form and mature in a cranio-
caudal sequence along the axial structures of the embryo, i.e. noto-
chord and neural tube. Speciﬁcally, myogenic progenitors, identiﬁed
by the expression of the Pair-ruled gene Pax3, are located in the dor-
sal dermo-myotome and are speciﬁed by Wnt and Shh signals ema-
nating from the axial structures and from the dorsal ectoderm
(Cossu and Borello, 1999; Reshef et al., 1998). The dorsal dermomyo-
tome also contains progenitors for dermis, tendons, vascular endo-
thelium and smooth muscle, some of which also express Pax3 and
migrate towards the dorsal aorta (Brent and Tabin, 2002; Esner et
al., 2006), while the anatomical location of skeletal myogenic progen-
itors is established, the exact lineage relationship among different cellevelopmental Biology, Univer-
et, London WC1E 6BT.
e), g.cossu@ucl.ac.uk
d de Quìmica y Biologìa, Uni-
NC-ND license. types of the dorsal somite and their differentiated tissue progeny re-
mains less deﬁned. For example, retroviral lineage marking, unex-
pectedly but unequivocally demonstrated the existence of a
common somitic progenitor for both endothelium and skeletal mus-
cle (Kardon et al., 2002). Moreover, in ovo electroporation experi-
ments have shown that BMP and Notch interfere with somitic cell
fate diverting them from skeletal muscle and inducing endothelial
and smooth muscle fate respectively (Ben-Yair and Kalcheim, 2008).
Thus it appears that in mammalian mesoderm, cell fate is established
in response to signaling molecules, locally produced by neighbor, dif-
ferentiated cells. Interfering with the expression of one or more spe-
ciﬁc molecules thus results in altered proportion of competent cells
undergoing a given differentiation pathway (Shin and O'Brien,
2009). While these reports focused on somites, much less is known
on the subsequent phases of pre-natal skeletal muscle histogenesis.
If multipotent progenitors exist in the somite and likely in other re-
gions of the mesoderm, they should presumably undergo more than
one differentiation pathways. In the last ten years a large number of
progenitor cells have been clonally isolated and expanded in vitro
from embryonic or adult mesoderm tissues, and shown to be multi-
potent (Asahara et al., 1997; Asakura and Rudnicki, 2002; De Bari et
al., 2003; Minasi et al., 2002; Reyes and Verfaillie, 2001; Rodriguez
et al., 2006; Tamaki et al., 2002; Toma et al., 2001; Torrente et al.,
2004). With the possible exception of mesenchymal stem cells, little
is known on the origin, lineage relationships and differentiation po-
tency of these cells.
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aorta and partially characterized as cells expressing early endothelial
and pericyte markers, and able to differentiate into different types of
solid mesoderm, both in vitro and also when transplanted in chick em-
bryos in ovo (Minasi et al., 2002) Embryonic mesoangioblasts undergo
smoothmuscle differentiation if exposed to TGF-β but do not spontane-
ously differentiate into skeletal muscle. However, if genetically labeled,
mesoangioblasts, cultured togetherwith unlabeled differentiatingmyo-
blasts undergo fusion and activate expression of muscle genes (Minasi
et al., 2002). It is still currently unknown what are the signals released
by differentiating muscle cells that activate myogenesis in mesoangio-
blasts. Here we show that muscle-derived Noggin – an antagonist of
BMP-2/4 activity - recruits cells from the dorsal aorta to skeletal myo-
genesis and this activity is competed by endothelial-derived BMP that
rather recruits these cells to a perithelial, smooth muscle fate.
Materials and Methods
Mice
MLC3F-nlacZ transgenic mice express nuclear β-gal under the
transcriptional control of the myosin light chain 1/3 F promoter/en-
hancer (Kelly et al., 1995). In Myf5nlacZ mice nuclear LacZ was tar-
geted to the Myf5 locus (Tajbakhsh et al., 1996). EGFP mice have
also been described (Hadjantonakis et al., 1998)
Co-culture of embryonic DA and C2C12 myoblasts
C2C12 myoblasts were plated at sub-conﬂuence (104x ml) as a
drop of 50 μl in a 0.5 cm area in the center of individual wells of a
24-well plate. After adhesion to the substrate, a single freshly isolated
embryonic DA (dissected from the thoracic upper segment to the iliac
bifurcation) from MLC3F-nlacZ embryo (Minasi et al., 2002) was
added, and covered by a drop of Matrigel™ diluted 1:4. The co-
culture was maintained in growth medium (DMEM+10% FBS) for
three days and then shifted to differentiation medium (DMEM+5%
horse serum). After three additional days the co-culture was ﬁxed
with paraformaldehyde 4% and then incubated with X-gal staining
solution overnight at 37 °C. C2C12 myoblasts, 10 T1/2 ﬁbroblasts,
D16 mesoangioblasts and H5V endothelial cells were described be-
fore (Minasi et al., 2002). In some of these experiments, cells were la-
beled with BrdU (5 μM) in complete medium for 2 hours at different
days of culture and in different experimental conditions.
DA-derived cells culture
Aorta-derived single cells were obtained by digestion of freshly
isolated DA (E11.5) in PBS without calcium-magnesium containing
0.45 mg/ml of collagenase V (Sigma) and 0.15 mg/ml of dispase
(Gibco) for 40 min at 37 °C. After recovery in 20% FBS containing
growth medium, cells were either cultured for 12 hours and then
stained with the antibodies described below, or separated by FACS
sorting analysis (see below) and then co-cultured with C2C12 myo-
blasts as described above.
Growth Factors
Growth Factor Reduced Matrigel™Matrix was purchased from BD
Bioscience. Recombinant human Noggin/Fc chimera and neutralizing
anti-human BMP-2/4 antibody from R&D Systems, Inc. BMP-2 and
BMP-4 from Peprotech.
Cryosections
Mouse embryos were ﬁxed in 4% PFA, washed in PBS, dehydrated by
washing them in PBS containing increasing concentration of sucrose(10, 20 and 30%), included in O.C.T™ and frozen in liquid nitrogen-
cooled isopentane. 7 μm-thick sections were cut with a Leica cryostat.
Immunoﬂuorescence
Adherent cell cultures, co-cultures and cryosections were processed
with the same standard protocol: after ﬁxation with 4% PFA, samples
were incubated with PBS 1% BSA 0.1% Triton X-100 (1 h at RT), blocked
with donkey or goat serum 10% in PBS (30 min at RT), incubated with
the primary antibody (1 h at RT), washed three times and incubated
with the secondary antibody (Alexa Fluor® conjugated (Invitrogen), di-
luted 1:500, 1 h at RT). Then the samples were washed three times and
incubatedwith Hoescht (1 mg/ml×5 min at RT), washed andmounted.
The primary antibodies used were: rabbit anti BMP-2 (1:250, Abcam),
rat anti CD31 (1:2, HybridomaBank),mouse antiMyHC (1:2,MF20, Hy-
bridoma Bank), goat anti Noggin (1:100, R&D Systems), mouse anti
smooth muscle heavy chain (1:250, Abcam), rabbit anti NG2 (1:200,
Chemicon), goat anti β-galactosidase (1:300, Biogenesis), rabbit anti
Myf5 (1:150, Santa Cruz), mouse anti MyoD (1:200, Dako), anti-
Phospho-Smad 1-5-8 (1:200 Cell Signaling Technology®), anti-BrdU
(1:100 Amersham GE Healthcare).
In situ hybridization
Previously published probes were: Bmp4 (Furuta et al., 1997), and
Noggin (Ybot-Gonzalez et al., 2007) In situ hybridization was carried
out as described by (Henderson et al., 1999) with samples ﬁxed for
2 h in 4% paraformaldehyde/phosphate buffered saline, then rinsed
with PBS-Tween, dehydrated in 100% methanol and stored at
−20 °C until processed for WISH. Antisense riboprobes were previ-
ously in vitro labelledwithmodiﬁed nucleotides (digoxigenin, Roche).
Semiquantitative RT-PCR
Total RNA was isolated from cells using TRIzolr (Invitrogen) or
RNeasyr Micro Kit (Quiagen). cDNA was synthesized from total
RNA previously treated with DNAse I, primed with random
primers, and then reversed transcribed with Moloney murine leu-
kemia virus reverse transcriptase. PCR protocols for amplify tran-
scripts for BMP-2, Noggin and BMPR1A were performed as
described in (Goulley et al., 2007; Hager-Theodorides et al., 2002;
Van der Horst et al., 2002).PrimersBMP-2 Fw TGTGACCAGACTATTGGACACC (454 bp)
BMP-2 Rv AGTTCAGGTGGTCAGCAAGG
GAPDH Fw TTCACCACCATGGAGAAGGC (238 bp)
GAPDH Rv GGCATGGACTGTGGTCATGA
Noggin Fw TGAGCAAGAAGCTGAGGAGG (334 bp)
Noggin Rv GGATCGATCAAGTGTCTGGG
BMPR1A Fw GAAGTTGCTGTATTGCTGA (216 bp)
BMPR1A Rv GTAATACAACGACGAGCCAgarose beads
BMP-2 and BMP-4 were loaded in agarose beads (Afﬁ-GelR Blue
Gel, BioRad) incubating beads with growth factors at 3 μg/mL in PBS
0.1% BSA for 1 h at RT and then washed three times with PBS.
Transfection
C2C12 myoblasts were transfected with the shRNA for Noggin
containing plasmid using Lipofectamine™ and PLUS™Reagent (Invi-
trogen) and further selectioned with puromycin (2 μg/ml) for three
days.
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shRNAs for mouse Noggin and mouse BMP receptor type 1A were
purchased from Open Biosystems (Thermo Fisher Scientiﬁc Inc.,
USA). A third-generation lentiviral vector was produced as described
in (Sampaolesi et al., 2003). The lentiviral particles were produced by
transient transfection of the vector in association with the packing
vectors (pREV, pD8.74 and pVSV-G) in HEK293T. After 30 h, the cul-
ture medium from transfected cells was ﬁltered with a 0.22 μm ﬁlter
and 250-times concentrated after centrifugation at 20.000 rpm for
2 h at 20 °C. The aorta-derived cells, plated 24 hours before, were
infected with the lentivirus containing the shRNA for BMPR1A at a
multiplicity of infection (MOI) of 400 for 12 h. Under these condi-
tions, more that 90% of the cell population was efﬁciently transduced.
As a control, a lentiviral vector expressing GFP expression was used
(Sampaolesi et al., 2003).
Real time PCR
The RNA from infected cellswas collected by RNeasymini (ormicro)
kit (QIAGEN) converted into double-strand cDNA with the cDNA sys-
tem kit ThermoScript RT-PCR (Invitrogen), according to the manufac-
turer's instructions. Real-time quantitative PCR analysis was carried
out on cDNA from isolated cells by using anMx3000P real-time PCR de-
tection system (Stratagene, La Jolla, CA). Each cDNA sample was ampli-
ﬁed in triplicate by using the SYBR Green Supermix (Invitrogen). Gene
expression proﬁling was achieved using the Comparative CT method
(DDCT) of relative quantiﬁcation (Livak and Schmittgen, 2001).
FACS analysis
Aorta-derived single cells were labeled with PE-conjugated rat
anti-mouse CD31 (BD Bioscience) and rabbit anti NG2 / secondaryFig. 1. Co-culture assay to test skeletal myogenic potency of embryonic dorsal aorta. A. Sche
aorta (from MLC3F-nlacZ embryos at E11.5) with C2C12 myoblasts (B) or with 10 T1/2 ﬁ
counting β-gal+nuclei (arrows). Scale bar: 100 μm.anti rabbit IgG FITC (Sigma) and then sorted in MoFlo System
(DAKO).
Alkaline Phosphatase Staining
Fixed cells were incubated in alkaline buffer containing NBT/BCIP
chromogenic solutions (Roche) for 30 min at RT.
Results
Embryonic dorsal aorta contains a cell population able to differentiate in
skeletal muscle
To study the regulation of skeletal myogenic differentiation of
aorta derived cells in vitro, co-cultures of freshly isolated embryonic
dorsal aorta (DA) and C2C12 myoblasts were performed as described
in Fig. 1A. Freshly isolated DA was dissected at E11.5 from MLC3F-
nlacZ mouse embryos that express nuclear lacZ under the transcrip-
tional control of the MLC1/3 F promoter of the myosin light chain
gene that restricts expression to striated muscle (Kelly et al., 1995).
Therefore, skeletal muscle differentiation of aorta-derived cells
could be quantitatively analyzed by counting β-gal+nuclei, usually
detected inside C2C12-derived myotubes. As shown in the Fig. 1B,
after 6 days of co-culture, several aorta-derived cells (an average of
50±15/dorsal aorta; n=7) differentiate into skeletal muscle, likely
by fusing with C2C12 myoblasts. This process was only observed in
co-cultures of DA with myoblasts. When DA was cultured with
10 T1/2 ﬁbroblasts (n=3, Fig. 1C) or embryonic neural tube (n=3,
data not shown) no β-gal+nuclei were detected. This myogenic
sub-population is not contaminated by somite-derived Myf5+ em-
bryonic myoblasts because the dorsal aorta, freshly dissected from E
11.5 Myf5-nlacZ embryos does not contain any β−gal+ cell (Suppl.
Fig. 1). At late stages of myogenic differentiation, all DA derived β-me showing the cell assay used. B,C. X-gal staining of co-cultures of embryonic dorsal
broblasts (C). Myogenic differentiation of aorta-associated progenitors was scored by
Fig. 2. Neutralization of BMP-2/4 activities enhances myogenic differentiation of aorta derived cells. A-C X-gal staining of co-cultures of embryonic DA and C2C12 myoblasts under
control conditions (A), after addition of Noggin (0.5 μg/ml) (B) and in the presence of BMP-2 (3 μM) loaded beads (C). Scale bars: 200 μm. D. Quantiﬁcation of effect of Noggin, anti
BMP-2/4 neutralizing antibody and BMP-2 on differentiation index (number of β-gal+nuclei in C2C12 myotubes). The average of ﬁfteen different co-cultures (each experimental
condition in triplicate) is shown. Differences were found to be signiﬁcant: noggin, P=0.0036; anti BMP-2/4, P=0.0126; BMP-2, P=0.0096, using unpaired two-tailed t-Test.
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Myf5, indicating that, as expected, skeletal myogenesis is related to
Myogenic Regulatory Factor (MRF) expression (Suppl. Fig. 2).
Primary embryonic and fetal myoblasts are more potent than C2C12
myoblasts in activating skeletal myogenesis in cells from the DA
C2C12 are an established cell line and, although widely used for
studying myogenesis, they may not entirely correspond to primary
myoblasts, also because they were derived from adult satellite cells.
To verify that the myogenic inductive potency was also present in
myogenic cells freshly isolated from embryos or fetuses, we repeated
the experiment by co-culturing DA fromMLC3F-nlacZmouse embryos
with primarymyoblasts puriﬁed fromMyf5GFP embryos and fetuses at
E11.5 and E15.5 respectively. The results indicated that primary em-
bryonic myoblasts were approximately 8 times (Figs. 3A,D) and fetal
myoblasts 4 times (Figs. 3C,D) times more effective than C2C12 in ac-
tivating myogenesis of DA cells. Since adult primary satellite cells
appeared equivalent to C2C12 myoblasts in their ability of activating
myogenesis in DA cells (data not shown), it is likely that this potential
is inversely related to developmental age. However, due to the difﬁ-
culty of synchronizing mating as to obtain MLC3F-nlacZ and Myf5GFP
mouse embryos of the right age on the same day, we carried out
most of the experiments with C2C12 myoblasts and repeated critical
ones with primary Myf5-GFP cells.
Neutralization of BMP-2/4 activities enhances myogenic differentiation
of aorta-associated progenitors
To identify growth factors that may regulate skeletal myogenesis
of DA cells we exposed the co-cultures to a large number of growth
factors and cytokines such as Wnt, FGF, Noggin and BMP inhibitors
that are known activate or enhance skeletal myogenesis and others
such as TGF-β, VEGF, PDGF-BB, BMP that rather inhibit myogenesis
and also inﬂuence recruitment and differentiation of mural cells dur-
ing vessel development (Armulik et al., 2005). Addition of BMP-2 tothe culture medium was not possible since the cytokine also inhibits
C2C12 myogenesis. Therefore agarose beads loaded with BMP-2 were
added close to the DA and were found to signiﬁcantly inhibit skeletal
muscle differentiation of DA cells (Figs. 2A,C, n=3). Consistent with
this observation, addition to the co-culture of a neutralizing antibody
speciﬁc for BMP-2/4 (Fig. 2D, n=3) caused a six fold enhancement of
myogenesis. Furthermore, we took advantage of the fact that primary
embryonic myoblasts are resistant to the inhibitory effect of BMP
(Biressi et al., 2007) and thus cultured E11.5 Myf5GFP puriﬁed myo-
blasts with DA from MLC3F-nlacZ mouse embryos in the presence of
BMP-2. As shown in Fig. 3B, many thin oligonucleated, typical embry-
onic myotubes formed in the presence of BMP-2 but the number of β-
gal+, DA derived nuclei was dramatically reduced, indicating that, as
expected, BMP-2 does not inhibit embryonic myogenesis but pre-
vents the ability of embryonic myoblasts and myotubes to activate
skeletal myogenesis in DA cells (compare Figs. 3A with B).
On the other hand, the addition of Noggin to the co-cultures en-
hanced fourfold muscle differentiation of DA derived cells (Fig. 2B,
n=3). This was not due to enhanced myogenesis of C2C12 cells,
since their differentiation was similar with or without Noggin
(Suppl. Figs. 3A,B). To test whether Noggin induces skeletal myogen-
esis in a larger number of DA cells, or rather promote their prolifera-
tion, we administered BrdU to co-cultures, with or without Noggin,
for 3 hours on day 2 and 4. The results showed that at day 6, almost
all β-gal+, control or treated cells had incorporated BrdU (arrows
show examples in Suppl. Fig. 4), thus suggesting that a major prolif-
erative effect of Noggin is unlikely, also considering that at this em-
bryonic stage cells proliferate actively in serum containing medium.
Interestingly, addition of Noggin to co-cultures of primary Myf5GFP
myoblasts and DA did not signiﬁcantly enhance myogenesis
(Fig. 3D), suggesting that no further enhancement of skeletal myo-
genesis was possible, at least under these experimental conditions.
Assuming that a dissected dorsal aorta contains approximately
50,000 cells, we may indirectly conclude that approximately 1% of
the total cell population would be competent to respond to myogen-
esis inducing signals such as Noggin.
Fig. 3. Primary embryonic and fetal myoblasts are more potent than C2C12 cells in pro-
moting myogenic differentiation of aorta derived cells. A-B. X-gal staining of co-
cultures of embryonic DA and E11.5 Myf5GFP puriﬁed embryonic myoblasts under
control conditions (A) and after addition of BMP-2 (3 μM) (B). C. X-gal staining of co-
cultures of embryonic DA and E16.5 Myf5GFP puriﬁed fetal myoblasts under control
conditions. Scale bars: 200 μm. D. Quantiﬁcation of differentiation index (number of
β-gal+nuclei in myotubes or myocytes) in co-culture of DA cells with embryonic myo-
blasts (± BMP-2 or±Noggin) or with fetal myoblasts. An average of four different co-
cultures (each experimental condition in triplicate) is shown.
Fig. 4. BMP-2 is expressed in embryonic dorsal aorta. Immunoﬂuorescence for CD31
(A) and BMP-2 (B) of a dissected dorsal aorta from a mouse embryo at E11.5; merged
image of a transverse cryosection of a similar embryo is show in C. BMP is localized in
and around the endothelium of dorsal aorta. Scale bar: 80 μm. D. RT-PCR analysis for
BMP-2 expression in different cells lines and embryonic DA. MW: molecular markers;
H5V: mouse endothelial cell line; D16: mouse mesoangioblast clone; C2mb: C2C12
myoblasts; C2mt: C2C12 myotubes; DA: embryonic Dorsal Aorta. E: In situ hybridiza-
tion with a BMP2 probe of a dissected DA, with adjacent mesoderm. Note that signal
(violet) is in the internal region surrounding the residual blood (red). F-H. Immunoﬂu-
orescence for CD31 and BMP-2 in embryonic DA-derived cells after 12 hours in culture.
Note co-expression of CD31+ and BMP-2 (F). Scale bar: 15 μm. Noggin is expressed
during myoblast differentiation.
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chordin and gremlin had no effect (n=3, data not shown). Similarly
Wnt3A, Wnt7A, TGF-β1, VEGF and PDGF-BB had no effect (n=3, data
not shown).
BMP-2 is expressed by endothelial cells in embryonic dorsal aorta
To determine if BMP-2 is expressed in the embryonic DA, immu-
noﬂuorescence, in situ hybridization and semiquantitative RT-PCR as-
says were performed. Fig. 4A shows that isolated dorsal aorta and
associated inter-somitic arteries are brightly stained by an anti-
CD31 antibody (green) and also by an antibody (red) recognizing
BMP-2/4 (Fig. 4B). This is also evident in a transverse section showing
a merged image (Fig. 4C). Since immunostaining of tissue section
with antibodies against secreted molecules exposes to the risk of
background staining (despite very low signal detected with second-
ary antibody alone) we conﬁrmed this observation by a number of
methods: semiquantitative RT-PCR assay shows that the transcripts
for BMP-2 are present in the embryonic DA and H5Vmurine endothe-
lial cell line but not in differentiating or differentiated C2C12 cells
(Fig. 4D). In situ hybridization with a probe recognizing BMP2 strong-
ly stained isolated dorsal aorta (appearing violet in Fig. 4E, blood ap-
pears red inside) indicating that the message is transcribed as
expected. Finally, almost all freshly isolated cells, obtained by enzy-
matic digestion of freshly isolated DA that were stained by an anti-
CD31 antibody (green) were also stained by the anti BMP antibody
(red) as shown in Figs. 4F-H. These results were conﬁrmed in a func-
tional assay. Suppl. Fig. 5 shows that the addition of conditioned me-
dium from ten DA, cultured as explants, to C2C12 myoblasts inducedinhibition of myogenesis and expression of the pericyte marker alka-
line phosphatase, similar to the addition of BMP-2 to the culture me-
dium. This effect was reversed by the simultaneous addition of
neutralizing anti BMP2/4 antibody, thus conﬁrming that cells of the
aorta explants secrete BMP2.
Noggin is expressed during myoblast differentiation
Noggin is a secreted protein that binds with high afﬁnity and an-
tagonizes the biological activity of several BMP proteins such as
BMP-2, BMP-4 and BMP-7 (Zimmerman et al., 1996). Since Noggin
did enhance skeletal myogenesis of DA derived cells in vitro, we per-
formed immunoﬂuorescence and semiquantative RT-PCR analysis for
Noggin in differentiating myoblasts and myotubes during in vitro dif-
ferentiation and in vivo mouse limb development. Figs. 5A-B show
that, Noggin is immune-detected predominantly in MyHC
+differentiated myotubes in vitro (A, B) and in MyHC+newly
Fig. 6. BMP-4 induce aortic mural cells to differentiate in smooth muscle. A. X-gal stain-
ing of a co-culture in which BMP-4-loaded agarose beads (arrows) were added close to
the dissected DA. One myotube containing few Β-gal+nuclei is shown by the arrow-
head. Scale bar: 100 μm. B. immunoﬂuorescence for smooth muscle myosin heavy
chain (SM-MyHC) of the same co-culture (the area shown in the dot line square in
A). Scale bar: 60 μm. C-E. Immunoﬂuorescence for smooth muscle myosin heavy
chain in a co-culture of a HGFP; MLC3F-nlacZ dorsal aorta and C2C12 myoblasts. GFP
+cells (and DAPI) are shown in C, SM-MyHC+cells (red) in D; the double positive
cells, shown in the merged image in E originate from the aorta. Scale bar: 50 μm. F.
RT-PCR of Control and BMP-2 treated C2C12 cells for the expression of Calponin
(Calp), Smooth Alpha Actin (SMA) and Gapdh. RNA extracted from E11.5 embryo (E)
was used as a positive control.
Fig. 5. A,B. Immunoﬂuorescence for Noggin (B) in C2C12 myotubes at day 3 of differen-
tiation. Reactivity for Noggin co-localizes with myosin heavy chain (MyHC) in multinu-
cleated myotubes (A). Merged image is shown in the inset. Scale bar: 50 μm. C.
Immunoﬂuorescence for Noggin in a cryosection of a limb of a mouse embryo
(E14.5). The arrow shows one MyHC+ (C) muscle ﬁber showing reactivity for Noggin
(D). Merged image is shown in the inset. E. RT-PCR analysis for Noggin expression in
C2C12 myoblasts at day 1, 3 and 5 of differentiation (lanes 1–3). Noggin is not
expressed in 10 T1/2 ﬁbroblasts (lane 5). Lane 4 is the negative control of the PCR
reaction.
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Noggin markedly increase during differentiation of C2C12 myoblasts
(lanes 1–3, Fig. 5E) but are absent in 10 T1/2 ﬁbroblasts (lane 5).
These results demonstrate that this BMP antagonist is expressed by
differentiating skeletal muscle cells in vitro and in vivo.
BMP-4 induces aortic mural cells to differentiate in smooth muscle
To evaluate whether BMP-2/4 inhibits differentiation of DA de-
rived in skeletal muscle because it drives differentiation towards the
default smooth muscle phenotype, we analyzed co-cultures of DA
with C2C12 in which BMP-4 was loaded onto beads as described in
Fig. 2. Figs. 6A,B shows that many cells, adjacent to BMP-4-loaded
beads, differentiated into smooth muscle as revealed by immune de-
tection of smooth muscle myosin heavy chain (SM-MyHC). To distin-
guish between DA-derived and C2C12 cells, in a subsequent
experiment the DA was dissected from EGFP/MLC3F-nlacZ embryos.
Figs. 6C-E shows that the expression of smooth muscle myosin
heavy chain (SmMyHC) is associated to GFP+aorta-derived cells,
even though not all the GFP+cells expressed SmMyHC. To rule out
the possibility that BMP may activate smooth muscle genes in
C2C12 cells, we treated these cells alone with BMP-2 and after
5 days we analyzed by RT-PCT the expression of the smooth muscle
marker Calponin. As shown in Fig. 6F, BMP-2 did not induce expres-
sion of this gene in C2C12 cells, that readily express SMA as the
untreated cells. These results indicate that BMP-2 stimulates the dif-
ferentiation of DA-derived cells into smooth muscle.
Myoblast-derived noggin is required for in vitro myogenic differentiation
of aorta-derived cells that is also enhanced by silencing of BMPR1A
To determinate whether Noggin synthesized by muscle cells is re-
quired for differentiation of DA derived cells we knocked-down Nog-
gin in C2C12 myoblasts by transfection of a speciﬁc siRNA-containing
plasmid. Fig. 7A shows that under these conditions, Noggin tran-
scripts level decreased to approximately 55% of control myotubes
(evaluated by band quantiﬁcation of RT-PCR products and Real TimePCR: Fig. 7B). Fig. 7C shows that the differentiation of DA derived
cells is strongly inhibited (b 40% of control) when the embryonic
DA are plated with C2C12 transfected with the siRNA-contained plas-
mid. The process of differentiation of C2C12 myoblasts transfected
with the shRNA containing plasmid was not compromised since
they formed multinucleated myotubes as control cultures (Suppl.
Figs. 3A,C). On the other hand, silencing BMP signaling should en-
hance myogenesis of DA derived cells. BMP-dependent signaling is
mediated by two membrane receptors BMPRI and BMPRII, which di-
merize after ligand binding and activate a Smad1,5,8-dependent cas-
cade (ten Dijke et al., 2003). Fig. 7A shows that after transduction of
the Dorsal Aorta with a lentiviral vector expressing a speciﬁc shRNA
for the BMP receptor type 1A, the levels of this transducer receptor
for BMP-2 was reduced to 40% of control myotubes (evaluated by
band quantiﬁcation of RT-PCR products and Real Time PCR: Fig. 7B)
and the differentiation of DA derived cells into skeletal muscle was
enhanced twofold (Fig. 7C). Altogether these results suggest that in-
terference with the BMP pathway, either by modulation of Noggin
levels or by downregulation of the BMP membrane receptor, modu-
lates the skeletal myogenic potency of DA derived cells.
Aorta derived cells endowed with myogenic potency express the NG2
proteoglycan
As shown in Fig. 8A, mouse embryonic DA at E11.5 is composed ba-
sically by CD31+ endothelial and by NG2+ perivascular cells. NG2 is a
Fig. 8. Aorta-derived cells endowed with skeletal myogenic potency express NG2. A.
Immunoﬂuorescence for CD31 and NG2 expression in a transversal cryosection of a
dorsal aorta (mouse embryo at E11.5). Scale bar: 50 μm. B. A representative FACS pro-
ﬁle of freshly isolated DA-derived cells, labeled with antibodies against CD31 or NG2. C.
Histogram showing the myogenic potential of each sorted fraction from three different
experiments, evaluated as the number of β-gal+nuclei contained in C2C12 myotubes,
normalized by the number of sorted cells. Values plotted correspond to averages±SD.
Cells generating β-gal+clones were signiﬁcantly enriched in the NG2+ fraction (vs all
other positive fractions: ***Pb0.001) by the ANOVA Test. DN: Double Negative;
DP: Double Positive. D. Double IF of NG2+ cells, co-stained with an antibody recogniz-
ing phospho-SMAD 1-5-8, showing co-expression in the majority of the cells.
Fig. 7. Silencing of Noggin in myoblasts and of BMPRIA in dorsal aorta. A. Semi-
quantitative RT-PCR for Noggin of total RNA from C2C12 myoblasts transfected with
a plasmid expressing either GFP or shRNA for Noggin. B. Semi-quantitative RT-PCR
for of BMP receptor 1A of total RNA from explanted Dorsal Aorta transduced with a len-
tivector expressing either GFP or SiRNA for BMPR1A. Data show one representative of
four different experiments. Differences were found to be signiﬁcant (P=0.007 and
Pb0.001, respectively) using unpaired two-tailed t-Test. C. Real-time quantitative RT-
PCR for Noggin and BMPR1A of total RNA of C2C12 and aorta-derived cells transduced
with silencing vectors as described in A,B. Data are the average (± SD) of four different
experiments. Differences were found to be signiﬁcant (Pb0.002 and Pb0.001, respec-
tively) using unpaired two-tailed t-Test. D. Quantiﬁcation of the effect of Noggin or
BMPR1A silencing on myogenic differentiation of aorta-derived cells co-cultured with
C2C12 myoblasts. Data plotted correspond to four different paired co-cultures after
four different pairs of infections. Difference was found to be signiﬁcant (P=0.015
and P=0.024) using unpaired two-tailed t-Test .
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onic and adult pericytes (Ozerdem and Stallcup, 2004). To determine
which cell type of the embryonic DA express a skeletalmyogenic poten-
cy, a ﬂuorescence activated cell sorting (FACS) analysis of DA-derived
cells was performed. FACS analysis of single cell suspension obtained
bymild enzymatic digestion of freshly isolated DA showed that approx-
imately 20% of the total population expressed NG2, 6% CD31 and 4%
both antigens (Fig. 8B). After cell sorting, the same number of cells
(5×103) from each sub-population was co-cultured with C2C12 myo-
blasts and the number of β-gal+nuclei in C2C12 myotubes was evalu-
ated. These experiments showed that the NG2+ cell fraction contains
the large majority of the myogenic progenitors (Fig. 8C). Many freshly
isolated NG2+ cells were found to express phospho-SMAD 1-5-
8 (Fig. 8D) suggesting that, within the aorta wall, these cells respond to
BMP, and are therefore likely primed to a smooth muscle fate, to which
they may escape if they migrate away from the endothelium.
Aorta-associated progenitors with myogenic potency are distributed
along a cranio-caudal, temporal gradient
We investigated whether DA cells able to activate skeletal myogen-
esis are equally distributed along the cranio-caudal axis of theembryonic dorsal aorta. To this aim the DA were dissected from
MLC3F-nlacZ embryos at different stages of development and further
subdivided in a thoracic, an abdominal and a pelvic segment as indicat-
ed in the upper scheme of Fig. 9. Each segment taken from the same DA
(n=3), was cultured with C2C12 myoblasts and, after differentiation,
the number of β-gal+cells was recorded. Results indicated that at
E10.5 the large majority of myogenic cells is present in themost cranial
segment, with very few myogenic cells present in the other segments
(Fig. 9 upper lane). In contrast, when the same experiment was repeat-
ed at E12.5 the results were completely different, with a very large pre-
dominance of myogenic cells in the iliac segment (Fig. 9, lower lane).
Interestingly, the abdominal segment was always almost devoid of
myogenic cells, even at E11.5, when one would predict that the wave
of myogenic cells should be present (Fig. 9 middle lane). These results
suggest that proliferating competent cells able to respond to skeletal
myogenic induction are unequally distributed along the cranio-caudal
axis and this distribution changes with time, roughly corresponding to
the cranio-caudal wave of skeletal myogenic differentiation of somite-
derived myoblasts in the embryonic trunk (Tajbakhsh and
Buckingham, 1994). The lower amount of β-gal+nuclei associated to
abdominal region of DA suggests the presence of some inhibitory factor
of muscle differentiation of DA derived cells, likely the high levels of
BMP-2 (or BMP-secreting cells) in the AGM region.
Discussion
The identiﬁcation of signaling molecules that instruct competent
cells to adopt one or another cell fate remains a central issue in devel-
opmental biology.
In the case of skeletal muscle the main signaling molecules that ac-
tivate myogenesis in the somites and the responding genes were iden-
tiﬁed and characterized in the last twenty years (reviewed in
Fig. 9. Distribution of myogenic aorta-associated progenitors follows a cranio-caudal wave during embryonic development. A. Scheme depicting the cranio-caudal level of dissec-
tion of the dorsal aorta. B-J. X-gal staining of co-cultures of C2C12 myoblasts with the different regions of DA (A, anterior B,E,H; M, medial, C,F,I; P, posterior, D,G,J) as shown in the
upper drawing. Co-cultures of corresponding segments of DA dissected from embryos at E10.5 (B-D), E11.5 (E-G) and E12.5 (h-J) are shown. Scale bar: 80 μm. K. Quantiﬁcation of β-
gal+nuclei in co-cultures with C2C12 myotubes at the three different stages of development. Number in the ordinate show the n° of β-gal+nuclei/ explanted segment of the dor-
sal aorta. Each dot represents the result of a separate experiment, each performed in triplicate.
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curs in somites for all myogenic progenitors and thus it remains to be
understood why certain progenitors differentiate immediately to form
the myotomes while others proliferate and differentiate later during
pre- and post-natal development. For example Pax3+/MRF- myoblasts
at E11.5, once explanted in vitro differentiate immediately into thin
myotubes, thus suggesting that they do not require (and likely had al-
ready received) instructive signalingmolecules needed to initiate myo-
genesis. The situation is different for a number of ill-deﬁned mesoderm
cells that do not spontaneously undergo myogenesis but do so if co-
cultured with genetically distinguishable bona-ﬁde myogenic cells.
These “occasional”myogenic progenitors (Cossu and Biressi, 2005) are
clearly competent to be recruited tomyogenesis but are not committed
to a myogenic fate. They may represent reserve cells to be utilized dur-
ing development or tissue repair but the precise role and the extent of
their contribution are still largely unknown.
Here we report that a sub-population of mesoderm cells, physical-
ly associated to the embryonic dorsal aorta, can undergo myogenic
differentiation if co-cultured with differentiating myogenic cells. Con-
tact is necessary, as conditioned medium or co-culture with physical
separation (trans-well) are not sufﬁcient to induce myogenesis
(Minasi et al., 2002) and unpublished results), and fusion is themost likely underlying mechanism as most β-gal+nuclei are found
inside multinucleated myotubes. Even when DA cells are co-
cultured with primary embryonic myoblasts, that form thin oligonu-
cleated myotubes, more than one DA-derived nucleus are often
found in the same cytoplasm, even though, mononucleated, Β-gal
+cells can be detected. Interestingly, when DA cells are co-cultured
with embryonic myoblasts, approximately 8 times more cells are
recruited to myogenesis, in comparison with C2C12 cells, whereas
this value is decreased to fourfold when the co-culture is performed
with fetal myoblasts, suggesting that the ability of newly forming
myotubes to recruit DA cells is inversely proportional to developmen-
tal age; indeed primary adult satellite cells recruit to myogenesis ap-
proximately the same number of cells than C2C12 which were
derived from mouse adult satellite cells.
In this work we show that this process is positively regulated by
Noggin (but not by other BMP inhibitors) and negatively by BMP2
that rather directs DA cells to a perithelial/smooth muscle fate. It is
somewhat surprising that other BMP inhibitors such as Chordin, Follis-
tatin and Gremlin did not show any activity much as other unrelated
signaling molecules. It will be interesting to investigate the mechanism
through which Noggin activates skeletal myogenesis in DA cells: our
current data only suggest that Noggin may not promote proliferation
Fig. 10. Proposed model for cell fate regulation of vessels-associated progenitors. Dur-
ing embryonic development, cell fate of vessel-associated progenitors depends upon a
competition between BMP-2, synthesized by the endothelium (inhibiting skeletal
myogenesis and promoting smooth myogenesis) and its antagonist Noggin, secreted
by myoﬁbers and recruiting progenitors to skeletal myogenesis.
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these cells and/or inhibits expression of genes that drive smoothmuscle
differentiation such asMyocardin or Necdin (Brunelli et al., 2004; Hu et
al., 2003) beside inhibiting BMP activity, as known.
Several reports indicate that BMP-2 and BMP-4, in addition to
their canonical role as osteogenic factors, can also induce smooth
muscle markers (Lagha et al., 2009) and it is well known that BMP
signaling inhibits skeletal myogenesis (Duprez et al., 1996;
Yamaguchi et al., 1991). BMP is expressed in the endothelium at the
proper time as previously reported and conﬁrmed in this study
(Durand et al., 2007) and thus may play this role in vivo by promoting
smooth at the expense of skeletal myogenesis. On the other hand we
show here that Noggin is expressed in developing muscle ﬁbers in
vivo, consistent with a possible role in recruiting aorta cells to skeletal
myogenesis. Moreover, gain and loss of function experiments by both
neutralizing antibodies and silencing RNA support this conclusion.
Unfortunately, the relative inaccessibility of the mammalian embryo
in this speciﬁc period of development prevents in utero experiments
that have been rather performed in ovo with the chick embryo.
Sorting experiments identiﬁed the DA cells endowed with this
myogenic potency as pericytes. These data conﬁrm previous trans-
plantation experiments in the chick embryo (Minasi et al., 2002).
However it should be considered that pericytes are still poorly char-
acterized and likely heterogenous cells, part of which may derive
from endothelial cells. In vivo lineage tracing experiments are in pro-
gress to deﬁne the fate of early endothelial cells (Azzoni et al. under
revision) but similar experiments are not feasible for pericytes since
none of the genes expressed in these cells (NG2, alkaline phospha-
tase, smooth muscle actin, desmin, PDGF receptor β, etc.) is unique
to pericytes, at least pre-natally.
Finally, we report that DA cells are not homogeneously distributed
along the cranio-caudal axis of the dorsal aorta but appear to follow a
cranio-caudal wave that roughly corresponds to the cranio-caudal
progress of skeletal myogenesis along the main body axis
(Tajbakhsh and Buckingham, 1994). This would suggest that develop-
ing skeletal muscle recruits mesoderm progenitors to a myogenic fate
at the time when primary multinucleated ﬁbers are forming by fusion
of myoblasts. Right after formation of skeletal muscle, new vessels
grow in between newly formed ﬁbers and, as known, endothelial
cells recruit mesoderm progenitors to a pericyte fate by secretion of
PDGF-BB. Thus it appears that a competition exists in the developing
skeletal muscle between endothelium and differentiating muscle to
recruit mesoderm progenitors to a perithelial or to a myogenic fateand that the local relative concentrations of BMP and Noggin, that
likely reﬂect physical contiguity, dictate this choice (Fig. 10).
Conclusions
These data suggest that during tissue histogenesis, endothelial
cells and newly formed skeletal muscle ﬁbers compete to recruit me-
soderm progenitors to different fates (pericytes vs skeletal muscle)
through a balance between BMP2 and Noggin.
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